Aethlon Medical (AEMD)

Overall impact
B (68)

Commentary

Aethlon Medical is a strong overall performer. With a 'B' rating of 67.9 for overall impact (78th percentile compared to all companies), Aethlon Medical ranks 66th out of 155 industry peers, behind American Shared Hospital Services, Accuray, BioSig Technologies and 62 others, and ahead of Hologic, Avinger, Adm Tronics Unlimited and 86 others. On top material causes for Aethlon Medical's industry (Healthcare Equipment), Aethlon Medical performs well in Conflict Free Mineral Production (96.0 score), Reduced Use of tobacco (84.6) and Access to Affordable Healthcare (80.1) and performs poorly in Humane Treatment of Animals (34.3 score).
Impact
Cause AEMD
Peer rank
Overall impact

Log in to view this information

Impact trend

Change in rating for overall impact

Log in to view this information

Company
Employees
9
Sector
Health Care
Industry
Health Care Equipment & Supplies
Sub-industry
Health Care Equipment
SASB industry
Medical Equipment & Supplies
Headquarters
Ca, United States
Share classes
AEMD
Description
Aethlon Medical, Inc. is a medical therapeutic company that focuses on developing products to treat cancer and life-threatening infectious diseases in the United States. The company develops Hemopurifier, a clinical-stage immunotherapeutic device for cancer and life-threatening viral infections, as well as for use in organ transplantation. Aethlon Medical was founded in 1984 and is based in San Diego, California.
Material causes
Ethos considers the following causes material for Aethlon Medical, based on its industry sub-industry Health Care Equipment. Learn more about material causes in our methodology overview.

This information is subject to Ethos' Terms and Conditions, which you can find here.

This information may not be used for corporate financing purposes (including, without limitation, ESG-linked loans, credit facilities, securities or structured products), as a basis for any financial instruments or products (including, without limitation, passively managed funds and index-linked derivative securities) or other products or services, to verify or correct data in any other compilation of data or index, to create any derivative works, nor to create any other data or index (custom or otherwise), without Ethos' prior written permission.

By browsing this site you agree to our use of cookies. Read more.
We use cookies on this site to enhance your user experience. By continuing to browse the site, you are agreeing to our use of cookies. Give me more info.